GlassScriptPhysician profile
Jay O Franklin
NPI 1932173945
$9,672.90
in general payments reported to CMS, 2019-2025
24 companies · $983 in 2025
The $983 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,243 · 2020: $279 · 2021: $1,446 · 2022: $1,913 · 2023: $1,450 · 2024: $2,361 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,011 · Travel and Lodging: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,011.07 |
| Travel and Lodging | $782.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,015.36 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $2,553.29 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Boston Scientific Corporation | $914.15 | 2019-2025 | Farapulse |
| Medtronic Vascular, INC. | $715.15 | 2019-2020 | |
| Atricure, INC. | $444.42 | 2021-2025 | Atriclip Laa Exclusion System |
| Medical Device Business Services, INC. | $303.88 | 2019 | |
| Cardiva Medical, INC. | $164.54 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Philips North America LLC | $106.67 | 2024-2025 | (Ck4) Mcot, (Ck7) Extended Holter, Extended Holter |
| Innovation Technologies INC | $64.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.08 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $45.82 | 2023-2024 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $39.86 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $36.45 | 2023-2024 | Camzyos |
| Pfizer INC. | $33.11 | 2022-2025 | |
| Scpharmaceuticals INC. | $26.47 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $24.44 | 2025 | |
| Ethicon US, LLC | $23.66 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.30 | 2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $16.50 | 2023 | |
| Kestra Medical Technology Services, INC. | $15.98 | 2025 | Assure Wcd |
| Cvrx, INC. | $15.94 | 2022 | |
| Merck Sharp & Dohme LLC | $13.59 | 2022 | |
| Astellas Pharma US INC | $13.28 | 2021 | |
| Tactile Systems Technology INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.